Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Non-Current Assets (2018 - 2026)

Alector's (ALEC) quarterly Non-Current Assets came in at $22.8 million in Q2 2026, down 38.87% year-over-year from $37.2 million in Q2 2025, and down 8.31% quarter-over-quarter from $24.8 million in Q1 2026.

Analysis

Alector (ALEC) Non-Current Assets (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Non-Current Assets for 9 consecutive years, with $22.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 38.87% year-over-year to $22.8 million in Q2 2026; TTM through Jun 2026 was $109.3 million, a 35.35% decrease from a year earlier, with the FY2025 full-year figure at $26.8 million, down 38.41% from the prior year.
  • Non-Current Assets was $22.8 million for Q2 2026 at Alector, down from $24.8 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $63.5 million in Q1 2022 and troughed at $22.8 million in Q2 2026.
  • A 5-year average of $48.4 million and a median of $52.6 million in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets declined 1.87% in 2023 and sank 40.38% in 2026, its largest moves.
  • Over 5 years, Non-Current Assets stood at $61.2 million in 2022, then declined by 8.48% to $56.0 million in 2023, then decreased by 22.37% to $43.5 million in 2024, then sank by 38.41% to $26.8 million in 2025, then slipped by 15.0% to $22.8 million in 2026.
  • The last three Non-Current Assets figures came in at $22.8 million (Q2 2026), $24.8 million (Q1 2026), and $26.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.96 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 938.60 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 24.78 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 468.65 Mn
10 Alector 274.68 Mn 101.88 Mn - 22.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.77 Mn
Mar 31, 2026 24.83 Mn
Dec 31, 2025 26.79 Mn
Sep 30, 2025 34.90 Mn
Jun 30, 2025 37.24 Mn
Mar 31, 2025 41.65 Mn
Dec 31, 2024 43.49 Mn
Sep 30, 2024 46.66 Mn
Jun 30, 2024 51.03 Mn
Mar 31, 2024 54.10 Mn
Dec 31, 2023 56.02 Mn
Sep 30, 2023 59.25 Mn
Jun 30, 2023 60.75 Mn
Mar 31, 2023 62.34 Mn
Dec 31, 2022 61.21 Mn
Sep 30, 2022 62.08 Mn
Jun 30, 2022 62.65 Mn
Mar 31, 2022 63.53 Mn
Dec 31, 2021 64.95 Mn
Sep 30, 2021 66.21 Mn